BridgeMD
Prevention study for HIV Prevention
Official title Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER)
ClinicalTrials.gov ID: NCT07509827
What this study is testing
- What it's testing
- This study aims to develop and evaluate a multi-component mHealth intervention (mHC and FRESH) to reduce HIV-related and intersectional stigma and improve PrEP use among HIV-negative young transgender women (TGW) in Thailand.
- Time commitment: about 6 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 29, men only
You may be able to join if
- Age 18-29 years
- Male sex at birth
- Self-identify as transgender woman/female spectrum
- HIV-negative (laboratory confirmed)
- Recent condomless sex
You likely can't join if
- Serious cognitive or psychiatric condition affecting consent
- Active suicidal ideation or major mental illness
- Medical contraindications to PrEP
- Enrolled in another HIV intervention study
See the full eligibility criteria
- Age 18-29 years
- Male sex at birth
- Self-identify as transgender woman/female spectrum
- HIV-negative (laboratory confirmed)
- Recent condomless sex
- Able to understand Thai
- Not on PrEP or poorly adherent (≤3 pills/week)
- Serious cognitive or psychiatric condition affecting consent
- Active suicidal ideation or major mental illness
- Medical contraindications to PrEP
- Enrolled in another HIV intervention study
The study team makes the final eligibility decision.
Where it's taking place
- Bangkok, Bangkapi, Thailand
- Bangkok, Building 3, Patpong, Surawong Road, Thailand
- Bangkok, Pathumwan, Thailand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling male, 18 years to 29 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bangkok, Bangkapi, Thailand; Bangkok, Building 3, Patpong, Surawong Road, Thailand; Bangkok, Pathumwan, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.